DDX41 and infection: When used in ADCC assays, Abs produced after 2 antigen exposures with hybrid immunity (i.e., infection and 1 vaccination) elicited comparable levels of ADCC against target cells expressing Wuhan-Hu-1 and Delta S (Figure 7B).